Loading...
Abivax S.A.
ABVX•NASDAQ
Healthcare
Biotechnology
$69.76
$1.16(1.69%)
Abivax S.A. (ABVX) Financial Performance & Income Statement Overview
Review Abivax S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-58.62%
↓ 58.62%
Operating Margin
-1168.96%
↓ 1168.96%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-1190.99%
↓ 1190.99%
ROE
-105.50%
↓ 105.50%
ROIC
-77.76%
↓ 77.76%
Abivax S.A. (ABVX) Income Statement & Financial Overview
Review Abivax S.A.'s (ABVX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $6.79M | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $378000.00 | $329000.00 | $32000.00 |
| Gross Profit | $6.79M | -$378000.00 | -$329000.00 | -$32000.00 |
| Gross Profit Ratio | $1.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $64.65M | $70.55M | $32.62M | $32.84M |
| SG&A Expenses | $22.16M | $21.53M | $6.58M | $5.15M |
| Operating Expenses | $86.78M | $92.08M | $39.21M | $37.99M |
| Total Costs & Expenses | $86.78M | $92.46M | $39.53M | $38.02M |
| Interest Income | $4.81M | $0.00 | $0.00 | $113000.00 |
| Interest Expense | $7.89M | $5.70M | $14.70M | $1.81M |
| Depreciation & Amortization | $171000.00 | $378000.00 | $329000.00 | $32000.00 |
| EBITDA | -$79.83M | -$92.08M | -$39.21M | -$37.99M |
| EBITDA Ratio | -$11.76 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$80.00M | -$92.46M | -$39.53M | -$38.02M |
| Operating Income Ratio | -$11.79 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$4.31M | -$5.58M | -$14.65M | -$4.53M |
| Income Before Tax | -$84.30M | -$98.05M | -$54.19M | -$42.55M |
| Income Before Tax Ratio | -$12.42 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$2.67M | -$2.26M | -$2.23M | -$2.26M |
| Net Income | -$81.64M | -$95.79M | -$51.95M | -$40.29M |
| Net Income Ratio | -$12.03 | $0.00 | $0.00 | $0.00 |
| EPS | -$1.30 | -$1.98 | -$1.45 | -$1.81 |
| Diluted EPS | -$1.30 | -$1.98 | -$1.45 | -$1.81 |
| Weighted Avg Shares Outstanding | $62.92M | $48.29M | $35.90M | $22.30M |
| Weighted Avg Shares Outstanding (Diluted) | $62.92M | $48.29M | $35.90M | $22.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan